Moteur de recherche d’entreprises européennes
Financement de l’UE (1 863 125 €) : Comprendre la santé des femmes à travers le prisme de la sensibilité hormonale : génétique, mécanismes et trajectoires de santé Hor 03/02/2026 Programme de recherche et d'innovation de l'UE « Horizon »
Vue d’ensemble
Texte
Comprendre la santé des femmes à travers le prisme de la sensibilité hormonale : génétique, mécanismes et trajectoires de santé
Hormonal sensitivity conditions such as premenstrual syndrome, hormonal medication side effects, and (peri)menopausal symptoms affect billions of women but remain poorly understood. These conditions share a common factor: fluctuations in estrogen and progesterone levels that interact with endocrine, neurological, and metabolic systems, creating a continuum of individual hormone sensitivity. UNDERwHER aims to redefine the hormone sensitivity spectrum (HSS) by addressing its biological underpinnings and health impact. UNDERwHER builds on the applicant's recent work on 42 female reproductive health phenotypes, which demonstrated the value of genetics in understanding women’s health. By leveraging the data and opportunities in Estonian Biobank (N=140K women), we will combine self-reported HSS phenotypes with longitudinal healthcare data and app-based menstrual tracking. This unparalleled dataset will be used to characterize HSS static and dynamic subtypes through advanced clustering and modeling. Genome-wide association studies and functional genomic tools will identify genetic variants and biological pathways underlying HSS, revealing shared genetic links with other health domains. To evaluate the wider health impact, we will map the associations between HSS and long-term health outcomes, and by integrating genetic risk with observational data we will inform personalized hormonal medication recommendations. Finally, genetics-informed cellular models will uncover the transcriptomic effects of hormonal fluctuations, providing mechanistic insights. This research will help to i) provide a new concept on female hormonal health, ii) map the biological pathways linked to HSS to provide input for drug discovery, iii) propose evidence-based approaches for genetics-informed hormonal drug prescription, and iv) facilitate research on this topic by creating unique data resources and cellular models, with the ultimate goal of improving women's health and wellbeing.
| Tartu Ulikool | 1 863 125 € |
https://cordis.europa.eu/project/id/101231008
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel. L’état actuel est présenté à la page suivante : Tartu Ülikool AVOIG, Tartu linn, Estonie.